home / stock / pte / pte news


PTE News and Press, PolarityTE Inc. From 08/20/19

Stock Information

Company Name: PolarityTE Inc.
Stock Symbol: PTE
Market: NASDAQ
Website: polarityte.com

Menu

PTE PTE Quote PTE Short PTE News PTE Articles PTE Message Board
Get PTE Alerts

News, Short Squeeze, Breakout and More Instantly...

PTE - PolarityTE Granted Canadian Patent

SALT LAKE CITY , Aug. 20, 2019 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that the Canadian Intellectual Property Office has granted Patent No. 2 969 707 entit...

PTE - Eyes On Jackson Hole, Lyft And Disney D23 (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

PTE - Stocks To Watch: Eyes On Jackson Hole, Lyft And Disney D23

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Podcast listener? Subscribe now to receive Wall Street Breakfast by 8:00 a.m. every t...

PTE - PolarityTE to Present at Military Health System Research Symposium on Platform Technology for Treatment of Traumatic and Chronic Wounds

SALT LAKE CITY , Aug. 16, 2019 /PRNewswire/ --  PolarityTE, Inc. (NASDAQ: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present data on the potential for SkinTE™ and OsteoTE™ to ...

PTE - PolarityTE, Inc. (PTE) Management on Q2 2019 Results - Earnings Call Transcript

PolarityTE, Inc. (PTE) Q2 2019 Earnings Conference Call August 08, 2019 8:00 AM ET Company Participants Rich Haerle - Vice President of Investor Relations David Seaburg - President of Corporate Development Paul Mann - Chief Financial Officer Richard Hague - Chief Operating Offi...

PTE - PolarityTE EPS beats by $0.13, misses on revenue

PolarityTE (NASDAQ: PTE ): Q2 GAAP EPS of -$0.92 beats by $0.13 . More news on: PolarityTE, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

PTE - PolarityTE Reports Second Calendar Quarter 2019 Results

SALT LAKE CITY , Aug. 8, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today reported financial results for the second calendar quarter of 2019.  PolarityTE will host a con...

PTE - Notable earnings before Thursday's open

ACIW , AMC , AMRC , AZUL , BAM , BPMP , CAH , CBB , CCOI , CEVA , CNNE , COMM , COT , CRON , CSWI , EBIX , ECOM , EGRX , EPAM , ESPR , FOCS , FOLD , GOGO , GTT , HIMX , HMHC , IBP , KDP , KHC , KOP , KTB , LAUR , LITE , LKSD , LNG , MGA , MMS , MPAA , ...

PTE - PolarityTE: Pick This Regenerative Medicine Stock In 2019

PolarityTE ( PTE ), a micro-cap biotech in the regenerative medicine space, is truly a hidden gem. The company's lead product is an autologous, homologous SkinTE construct. SkinTE technology is used to regenerate functionally-polarized, hierarchically-organized, hair-bearing skin in full-thick...

PTE - PolarityTE to Report Calendar Second Quarter Financial Results on August 8, 2019

SALT LAKE CITY , July 25, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will report its calendar second quarter 2019 financial results by press release on...

Previous 10 Next 10